Denmark defends controversial Covid-19 pill

The tablet treatment against Covid-19 can prevent hospitalizations, says Danish Health Authority Director General Søren Brostrøm. He maintains it was the right decision to allow the use of the unapproved pill.
Søren Brostrøm, Director General at the Danish Health Authority | Photo: Philip Davali
Søren Brostrøm, Director General at the Danish Health Authority | Photo: Philip Davali
BY RITZAU, TRANSLATED BY DANIEL PEDERSEN

The Danish Health Authority is defending the use of the heavily criticized Covid-19 pill, Lagevrio (molnupiravir), which is meant to prevent serious infections.

Already a subscriber?Log in here

Read the whole article

Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

With your free trial you get:

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
Must be at least 8 characters, including three of: Uppercase, lowercase, numbers, symbols
Must contain at least 2 characters
Must contain at least 2 characters

Get full access for you and your coworkers

Start a free company trial today

Share article

Sign up for our newsletter

Stay ahead of development by receiving our newsletter on the latest sector knowledge.

Newsletter terms

Front page now

Further reading